We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan ANDA Sparks Another Effexor Suit

Law360 (July 10, 2007, 12:00 AM EDT) -- Wyeth has targeted Mylan Pharmaceuticals Inc. in yet another patent infringement suit involving the blockbuster depression and anxiety treatment Effexor.

In a complaint filed Friday with the U.S. District Court for the Northern District of West Virginia, Wyeth alleged that Mylan infringed three of its patents by seeking regulatory approval to sell a generic version of Effexor in the United States.

“The Mylan venlafaxine HCl extended-release capsules, when offered for sale, sold and/or imported, and when used as directed, would be used in a manner that...
To view the full article, register now.